(Q24243898)

30 October 2023

Hélène Audry

2

H

Audry

1 reference

30 October 2023

Jean Bourhis

3

J

Bourhis

1 reference

30 October 2023

Anthony TC Chan

4

A T C

Chan

1 reference

30 October 2023

Haluk Onat

5

H

Onat

1 reference

30 October 2023

Daniel TT Chua

6

D T T

Chua

1 reference

30 October 2023

Dora LW Kwong

7

D L W

Kwong

1 reference

30 October 2023

Muhyi Al-Sarraf

8

M

Al-Sarraf

1 reference

30 October 2023

Kwan-Hwa Chi

9

K H

Chi

1 reference

30 October 2023

Masato Hareyama

10

M

Hareyama

1 reference

30 October 2023

Singh F Leung

11

S F

Leung

1 reference

30 October 2023

Kullathorn Thephamongkhol

12

K

Thephamongkhol

1 reference

30 October 2023

Jean Pierre Pignon

13

J P

Pignon

1 reference

Cochrane Database of Systematic Reviews

30 October 2023

publication date

18 October 2006

0 references

published in

0 references

cites work

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Meta-analyses of randomised clinical trials in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

A note on quantifying follow-up in studies of failure time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004329.PUB2

7 January 2021